Mode
Text Size
Log in / Sign up
N/A Completed N=30 Randomized Treatment

BFA Treatment of Pain

Source: ClinicalTrials.gov NCT04464954 ↗
Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Apr 2024
Primary outcomePrimary: Effectiveness: Scale — 4.2; 5.1; 4.9; 3.2 score on a scale

Summary

The aim of this pilot study is to conduct an unblinded pilot randomized clinical study on the effectiveness and tolerability of auricular semi-permanent (ASP) vs intradermal (long), and pyonex needles in Battlefield Acupuncture (BFA) for the treatment of pain.

Outcome Measures

OutcomeResultp-value
PRIMARY
Effectiveness: Scale
4.2; 5.1; 4.9; 3.2; 3.7; 4.0
PRIMARY
Needle Tolerance: Questionnaire
2.0; 1.0; 1.8

Eligibility Criteria

**Patients must be able to get care at Nellis Air Force Base (a military installation) in order to participate in this study**

Inclusion Criteria

  • Active duty and DoD Beneficiaries aged 18 years or older
  • Acute (0-4 days) musculoskeletal injury
  • Injuries eligible for inclusion include all acute non-fracture related musculoskeletal injuries of the axial or peripheral skeleton.

Exclusion Criteria

  • Taking any opioid medications daily
  • Rheumatologic and autoimmune conditions which may be creating pain, such as rheumatoid arthritis, advanced osteoarthritis, or spinal stenosis
  • Contra-indication to needle use including known bleeding disorder and psychogenic issues related to needle use (e.g., needle-phobia)
  • Evidence or history of clinically significant immune deficiency, hematological, oncological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or severe allergic disease (including to metals and adhesive tapes) which could interfere with this study
  • Individuals with progressive radiating pain with motor-sensory changes (including weakness or numbness) related to their presenting pain complaint
  • Women who are pregnant, may be pregnant, or attempting to become pregnant
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04464954). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search